EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancements in extracellular vesicle therapy for neurodegenerative diseases

Ningyun Hu, Liang Chen iD, Guoku Hu iD, Rong Ma iD

Exploration of Neuroprotective Therapy · 2025

DOI: 10.37349/ent.2025.1004104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Neuroprotective Therapy, 2025. Verfasst von Ningyun Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases represent a significant and growing challenge to public health worldwide. Current therapeutic strategies often fall short in halting or reversing disease progression, highlighting the urgent need for novel approaches. Extracellular vesicles (EVs) have garnered attention as potential therapeutic agents due to their role in intercellular communication and their ability to transport bioactive cargo, including proteins, nucleic acids, and lipids. This review provides a comprehensive overview of the biology of EVs, their involvement in neurodegenerative diseases, and the potential for EV-based therapies. We discuss the different types of EVs, their biogenesis, and their cargo composition, emphasizing their relevance to neurological processes such as protein misfolding, neuroinflammation, and oxidative stress. Preclinical studies investigating EVs as carriers of therapeutic cargo and their ability to promote neuronal survival and regeneration are examined, with a focus on evidence from animal models of neurodegenerative disorders. We explore the use of EVs in the treatment of neurodegenerative diseases, including ongoing clinical trials, methods for EV isolation and modification, and future perspectives on personalized EV-based therapies designed to meet the unique needs of individual patients. Overall, this review highlights the potential of EVs as a promising avenue for neurodegenerative disease therapy, while also addressing key research gaps and translational hurdles that need to be overcome for their successful clinical implementation.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseExtracellular vesiclesHuntington’s diseaseParkinson’s diseaseamyotrophic lateral sclerosisexosomesmultiple sclerosis

Autor:innen und Institutionen

  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
  • Millard West High School, Omaha, NE 68135, USA.
  • Department of Computer Science and Technology, College of Mathematics and Computer, Shantou University, Shantou 515821, Guangdong, China.
  • Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.

ORCID-Profile: Liang Chen, Guoku Hu, Rong Ma

Förderung

  • NIDA NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Hu, N., Chen, L., Hu, G., & Ma, R. (2025). Advancements in extracellular vesicle therapy for neurodegenerative diseases. Exploration of Neuroprotective Therapy. https://doi.org/10.37349/ent.2025.1004104

Vancouver

Hu N, Chen L, Hu G, Ma R. Advancements in extracellular vesicle therapy for neurodegenerative diseases. Exploration of Neuroprotective Therapy. 2025. doi:10.37349/ent.2025.1004104

BibTeX
@article{Hu2025,
  author = {Hu, Ningyun and Chen, Liang and Hu, Guoku and Ma, Rong},
  title = {Advancements in extracellular vesicle therapy for neurodegenerative diseases},
  journal = {Exploration of Neuroprotective Therapy},
  year = {2025},
  doi = {10.37349/ent.2025.1004104}
}
Kostenlos starten →